Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1697, Issue 1-2, 2004, Pages 225-231

  Moffat, Jennifer F ^a   McMichael, Michelle A ^b   Leisenfelder, Stacey A ^a   Taylor, Shannon L ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Casein kinase II; Cdk; Cell cycle; CK2; Cyclin dependent kinase; HCMV; Herpes simplex virus type 1; Herpesvirus; HFF; HSV 1; Human cytomegalovirus; Human foreskin fibroblast; Kinase inhibitor; Purvalanol; Roscovitine; Varicella zoster virus

Indexed keywords

ANTIVIRUS AGENT; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; PURVALANOL; ROSCOVITINE; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; CELL CYCLE; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HERPES VIRUS; HERPES ZOSTER; HUMAN; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANTIVIRAL AGENTS; CELL LINE; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HERPESVIRUS 3, HUMAN; HUMANS; PURINES; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 1542298983     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2003.11.026     Document Type: Conference Paper

References (63)

1. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1986;1759-1816.
2. McGeoch D.J., Davison A.J. Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res. 14(4):1986;1765-1777.
3. Smith R.F., Smith T.F. Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J. Virol. 63(1):1989;450-455.
4. Stevenson D., Colman K.L., Davison A.J. Characterization of the putative protein kinases specified by varicella-zoster virus genes 47 and 66. J. Gen. Virol. 75(Pt. 2):1994;317-326.
5. Purves F.C., Roizman B. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proc. Natl. Acad. Sci. U. S. A. 89(16):1992;7310-7314.
6. Cunningham C., Davison A.J., Dolan A., Frame M.C., McGeoch D.J., Meredith D.M., Moss H.W., Orr A.C. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J. Gen. Virol. 73(Pt. 2):1992;303-311.
7. Littler E., Stuart A.D., Chee M.S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature. 358(6382):1992;160-162.
8. Ng T.I., Keenan L., Kinchington P.R., Grose C. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68(3):1994;1350-1359.
9. Ng T.I., Grose C. Serine protein kinase associated with varicella-zoster virus ORF 47. Virology. 191(1):1992;9-18.
10. Kenyon T.K., Lynch J., Hay J., Ruyechan W., Grose C. Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J. Virol. 75(18):2001;8854-8858.
11. Kenyon T.K., Cohen J.I., Grose C. Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane. J. Virol. 76(21):2002;10980-10993.
12. Reddy S.M., Cox E., Iofin I., Soong W., Cohen J.I. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72(10):1998;8083-8088.
13. Heineman T.C., Seidel K., Cohen J.I. The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J. Virol. 70(10):1996;7312-7317.
14. Besser J., Sommer M.H., Zerboni L., Bagowski C.P., Ito H., Moffat J., Ku C.C., Arvin A.M. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol. 77(10):2003;5964-5974.
15. Spengler M., Niesen N., Grose C., Ruyechan W.T., Hay J. Interactions among structural proteins of varicella zoster virus. Arch. Virol., Suppl. (17):2001;71-79.
16. Moffat J.F., Stein M.D., Kaneshima H., Arvin A.M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69(9):1995;5236-5242.
17. Moffat J.F., Arvin A.M. Varicella-zoster virus infection of T cells and skin in the SCID-hu mouse model. Zak O., Sande M.A. Handbook of Animal Models of Infection. 1999;973-980 Academic Press, San Diego.
18. Soong W., Schultz J.C., Patera A.C., Sommer M.H., Cohen J.I. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J. Virol. 74(4):2000;1864-1870.
19. Moffat J.F., Zerboni L., Sommer M.H., Heineman T.C., Cohen J.I., Kaneshima H., Arvin A.M. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. U. S. A. 95(20):1998;11969-11974.
20. Wagenaar F., Pol J.M., Peeters B., Gielkens A.L., de Wind N., Kimman T.G. The US3-encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus. J. Gen. Virol. 76(Pt. 7):1995;1851-1859.
21. Frame M.C., Purves F.C., McGeoch D.J., Marsden H.S., Leader D.P. Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J. Gen. Virol. 68(Pt. 10):1987;2699-2704.
22. Purves F.C., Longnecker R.M., Leader D.P., Roizman B. Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J. Virol. 61(9):1987;2896-2901.
23. Jerome K.R., Fox R., Chen Z., Sears A.E., Lee H., Corey L. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 73(11):1999;8950-8957.
24. Munger J., Roizman B. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. U. S. A. 98(18):2001;10410-10415.
25. Klupp B.G., Granzow H., Mettenleiter T.C. Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J. Gen. Virol. 82(Pt 10):2001;2363-2371.
26. Reynolds A.E., Wills E.G., Roller R.J., Ryckman B.J., Baines J.D. Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids. J. Virol. 76(17):2002;8939-8952.
27. Benetti L., Munger J., Roizman B. The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J. Virol. 77(11):2003;6567-6573.
28. Kinchington P.R., Fite K., Turse S.E. Nuclear accumulation of IE62, the Varicella-Zoster Virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74(5):2000;2265-2277.
29. Kinchington P.R., Fite K., Seman A., Turse S.E. Virion association of IE62, the Varicella-Zoster Virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. J. Virol. 75(19):2001;9106-9113.
30. Cohrs R.J., Gilden D.H., Kinchington P.R., Grinfeld E., Kennedy P.G. Varicella-Zoster virus gene 66 transcription and translation in latently infected human ganglia. J. Virol. 77(12):2003;6660-6665.
31. Mallory S., Sommer M., Arvin A.M. Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. J. Infect. Dis. 178(Suppl. 1):1998;S22-S26.
32. Mo C., Schneeberger E.E., Arvin A.M. Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells. J. Virol. 74(23):2000;11377-11387.
33. Moffat J., Ito H., Sommer M., Taylor S., Arvin A.M. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J. Virol. 76(16):2002;8468-8471.
34. Wang Z.-H., Gershon M.D., Lungu O., Zhu Z., Mallory S., Arvin A.M., Gershon A.A. Essential role played by the c-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J. Virol. 75(1):2001;323-340.
35. Olson J.K., Grose C. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J. Virol. 71(5):1997;4042-4054.
36. Yao Z., Jackson W., Grose C. Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J. Virol. 67(8):1993;4464-4473.
37. Olson J.K., Bishop G.A., Grose C. Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J. Virol. 71(1):1997;110-119.
38. Zhu Z., Hao Y., Gershon M., Ambron R., Gershon A. Targeting of glycoprotein I (gE) of varicella-zoster virus to the trans-Golgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecule. J. Virol. 70(10):1996;6563-6575.
39. Zhu Z., Gershon M.D., Hao Y., Ambron R.T., Gabel C.A., Gershon A.A. Envelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi network. J. Virol. 69(12):1995;7951-7959.
40. Olson J.K., Grose C. Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J. Virol. 72(2):1998;1542-1551.
41. Alconada A., Bauer U., Baudoux L., Piette J., Hoflack B. Intracellular transport of the glycoproteins gE and gI of the varicella-zoster virus. gE accelerates the maturation of gI and determines its accumulation in the trans-Golgi network. J. Biol. Chem. 273(22):1998;13430-13436.
42. Ye M., Duus K.M., Peng J., Price D.H., Grose C. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J. Virol. 73(2):1999;1320-1330.
43. Bosc D.G., Luscher B., Litchfield D.W. Expression and regulation of protein kinase CK2 during the cell cycle. Mol. Cell. Biochem. 191(1-2):1999;213-222.
44. Bosc D.G., Slominski E., Sichler C., Litchfield D.W. Phosphorylation of casein kinase II by p34cdc2. Identification of phosphorylation sites using phosphorylation site mutants in vitro. J. Biol. Chem. 270(43):1995;25872-25878.
45. Ezhevsky S.A., Ho A., Becker-Hapak M., Davis P.K., Dowdy S.F. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21(14):2001;4773- 4784.
46. Bresnahan W.A., Boldogh I., Thompson E.A., Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology. 224(1):1996;150-160.
47. Hayashi M.L., Blankenship C., Shenk T. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. U. S. A. 97(6):2000;2692-2696.
48. Jault F.M., Jault J.M., Ruchti F., Fortunato E.A., Clark C., Corbeil J., Richman D.D., Spector D.H. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69(11):1995;6697-6704.
49. Lu M., Shenk T. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J. Virol. 73(1):1999;676-683.
50. Bresnahan W.A., Boldogh I., Chi P., Thompson E.A., Albrecht T. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology. 231(2):1997;239-247.
51. Schang L.M., Phillips J., Schaffer P.A. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 72(7):1998;5626-5637.
52. Vesely J., Havlicek L., Strnad M., Blow J.J., Donella-Deana A., Pinna L., Letham D.S., Kato J., Detivaud L., Leclerc S. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224(2):1994;771-786.
53. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of Roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243(1-2):1997;527-536.
54. De Azevedo W.F., Leclerc S., Meijer L., Havlicek L., Strnad M., Kim S.H. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with Roscovitine. Eur. J. Biochem. 243(1-2):1997;518- 526.
55. Gray N., Detivaud L., Doerig C., Meijer L. ATP-site directed inhibitors of cyclin-dependent kinases. Curr. Med. Chem. 6(9):1999;859-875.
56. Somerville L., Cory J. Enhanced Roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res. 20(5B):2000;3347-3355.
57. Schang L., Bantly A., Knockaert M., Shaheen F., Meijer L., Malim M., Gray N., Schaffer P. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. J. Virol. 76(15):2002;7874-7882.
58. Snoeck R., Andrei G., De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs. 57(2):1999;187-206.
59. Linnemann C.C. Jr., Biron K.K., Hoppenjans W.G., Solinger A.M. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS. 4(6):1990;577-579.
60. Breton G., Fillet A.M., Katlama C., Bricaire F., Caumes E. Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy. Clin. Infect. Dis. 27(6):1998;1525-1527.
61. Bernhard P., Obel N. Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient. Scand. J. Infect. Dis. 27(6):1995;623-625.
62. Shugar D. Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases. Pharmacol. Ther. 82(2-3):1999;315-335.
63. Coen D.M., Schaffer P.A. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat. Rev., Drug Discov. 2(4):2003;278-288.